purchase customization

1 Study Coverage
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Market by Application
1.3.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Drugs and Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Drugs and Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Drugs and Vaccines Sales by Region
2.4.1 Global Influenza Drugs and Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Drugs and Vaccines by Region (2023-2028)
2.5 Global Influenza Drugs and Vaccines Revenue by Region
2.5.1 Global Influenza Drugs and Vaccines Revenue by Region (2017-2022)
2.5.2 Global Influenza Drugs and Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Top Influenza Drugs and Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Drugs and Vaccines in 2021
3.2 Global Influenza Drugs and Vaccines Revenue by Manufacturers
3.2.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2021
3.3 Global Influenza Drugs and Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Drugs and Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Drugs and Vaccines Sales by Type
4.1.1 Global Influenza Drugs and Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Drugs and Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Influenza Drugs and Vaccines Revenue by Type
4.2.1 Global Influenza Drugs and Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Drugs and Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Drugs and Vaccines Price by Type
4.3.1 Global Influenza Drugs and Vaccines Price by Type (2017-2022)
4.3.2 Global Influenza Drugs and Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza Drugs and Vaccines Sales by Application
5.1.1 Global Influenza Drugs and Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Drugs and Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Influenza Drugs and Vaccines Revenue by Application
5.2.1 Global Influenza Drugs and Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Drugs and Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Drugs and Vaccines Price by Application
5.3.1 Global Influenza Drugs and Vaccines Price by Application (2017-2022)
5.3.2 Global Influenza Drugs and Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza Drugs and Vaccines Market Size by Type
6.1.1 North America Influenza Drugs and Vaccines Sales by Type (2017-2028)
6.1.2 North America Influenza Drugs and Vaccines Revenue by Type (2017-2028)
6.2 North America Influenza Drugs and Vaccines Market Size by Application
6.2.1 North America Influenza Drugs and Vaccines Sales by Application (2017-2028)
6.2.2 North America Influenza Drugs and Vaccines Revenue by Application (2017-2028)
6.3 North America Influenza Drugs and Vaccines Market Size by Country
6.3.1 North America Influenza Drugs and Vaccines Sales by Country (2017-2028)
6.3.2 North America Influenza Drugs and Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Drugs and Vaccines Market Size by Type
7.1.1 Europe Influenza Drugs and Vaccines Sales by Type (2017-2028)
7.1.2 Europe Influenza Drugs and Vaccines Revenue by Type (2017-2028)
7.2 Europe Influenza Drugs and Vaccines Market Size by Application
7.2.1 Europe Influenza Drugs and Vaccines Sales by Application (2017-2028)
7.2.2 Europe Influenza Drugs and Vaccines Revenue by Application (2017-2028)
7.3 Europe Influenza Drugs and Vaccines Market Size by Country
7.3.1 Europe Influenza Drugs and Vaccines Sales by Country (2017-2028)
7.3.2 Europe Influenza Drugs and Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Drugs and Vaccines Market Size by Type
8.1.1 Asia Pacific Influenza Drugs and Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Drugs and Vaccines Market Size by Application
8.2.1 Asia Pacific Influenza Drugs and Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza Drugs and Vaccines Market Size by Region
8.3.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Drugs and Vaccines Market Size by Type
9.1.1 Latin America Influenza Drugs and Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Influenza Drugs and Vaccines Revenue by Type (2017-2028)
9.2 Latin America Influenza Drugs and Vaccines Market Size by Application
9.2.1 Latin America Influenza Drugs and Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Influenza Drugs and Vaccines Revenue by Application (2017-2028)
9.3 Latin America Influenza Drugs and Vaccines Market Size by Country
9.3.1 Latin America Influenza Drugs and Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Influenza Drugs and Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza Drugs and Vaccines Market Size by Type
10.1.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Drugs and Vaccines Market Size by Application
10.2.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country
10.3.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Corporation Information
11.1.2 Bristol Myers Squibb Overview
11.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol Myers Squibb Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Corporation Information
11.8.2 Sanofi Pasteur Overview
11.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Pasteur Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 Celgene
11.10.1 Celgene Corporation Information
11.10.2 Celgene Overview
11.10.3 Celgene Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Celgene Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Celgene Recent Developments
11.11 Seqirus
11.11.1 Seqirus Corporation Information
11.11.2 Seqirus Overview
11.11.3 Seqirus Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Seqirus Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Seqirus Recent Developments
11.12 Protein Sciences Corporation
11.12.1 Protein Sciences Corporation Corporation Information
11.12.2 Protein Sciences Corporation Overview
11.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Protein Sciences Corporation Recent Developments
11.13 Serum Institute of India
11.13.1 Serum Institute of India Corporation Information
11.13.2 Serum Institute of India Overview
11.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Serum Institute of India Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Serum Institute of India Recent Developments
11.14 Emergent Biosolutions
11.14.1 Emergent Biosolutions Corporation Information
11.14.2 Emergent Biosolutions Overview
11.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Emergent Biosolutions Recent Developments
11.15 BioCryst Pharmaceuticals
11.15.1 BioCryst Pharmaceuticals Corporation Information
11.15.2 BioCryst Pharmaceuticals Overview
11.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 BioCryst Pharmaceuticals Recent Developments
11.16 Alvogen
11.16.1 Alvogen Corporation Information
11.16.2 Alvogen Overview
11.16.3 Alvogen Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alvogen Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alvogen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Drugs and Vaccines Industry Chain Analysis
12.2 Influenza Drugs and Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Drugs and Vaccines Production Mode & Process
12.4 Influenza Drugs and Vaccines Sales and Marketing
12.4.1 Influenza Drugs and Vaccines Sales Channels
12.4.2 Influenza Drugs and Vaccines Distributors
12.5 Influenza Drugs and Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Drugs and Vaccines Industry Trends
13.2 Influenza Drugs and Vaccines Market Drivers
13.3 Influenza Drugs and Vaccines Market Challenges
13.4 Influenza Drugs and Vaccines Market Restraints
14 Key Findings in The Global Influenza Drugs and Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer